Shanghai Xuerong Biotechnology Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 575.92 million compared to CNY 566.5 million a year ago. Revenue was CNY 575.92 million compared to CNY 566.5 million a year ago. Net income was CNY 57.4 million compared to CNY 101.37 million a year ago. Basic earnings per share from continuing operations was CNY 0.13 compared to CNY 0.24 a year ago. Diluted earnings per share from continuing operations was CNY 0.13 compared to CNY 0.22 a year ago.